Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Review

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

       
Total article views   HTML views PDF downloads Totals
6,718 Dovepress* 6,718+ 2,702 9,420
Totals 6,718 2,702 9,420
*Since 8 February 2008
+Since July 2016

View citations on Google Scholar